N5501
Nω-硝基-L-精氨酸
synthetic, ≥98% (TLC), Nitric oxide synthase inhibitor, powder
别名:
L-NNA, N5-（硝酰胺基）-L-2,5-二氨基戊酸, NG-NO2-L-精氨酸
产品名称
Nω-硝基-L-精氨酸, ≥98% (TLC)
生物来源
synthetic
质量水平
方案
≥98% (TLC)
表单
powder
mp
257 °C
溶解性
1 M HCl: 50 mg/mL, clear, colorless to faintly yellow
SMILES字符串
N[C@@H](CCCNC(=N)N[N+]([O-])=O)C(O)=O
InChI
1S/C6H13N5O4/c7-4(5(12)13)2-1-3-9-6(8)10-11(14)15/h4H,1-3,7H2,(H,12,13)(H3,8,9,10)/t4-/m0/s1
InChI key
MRAUNPAHJZDYCK-BYPYZUCNSA-N
基因信息
human ... NOS1(4842), NOS2(4843), NOS2B(201288), NOS2C(645740), NOS3(4846)
mouse ... Nos2(18126)
rat ... Grin2a(24409), Nos1(24598)
正在寻找类似产品? 访问 产品对比指南
相关类别
应用
Nω-硝基-L-精氨酸已被用于：
- 作为一氧化氮合成酶 (NOS) 抑制剂，用于测量细胞色素C还原检测中一氧化氮（NO）衍生物的释放量
- 收缩研究用纤维束的预处理
- 作为 NOS 抑制剂表征云南红豆杉 细胞中NO的生成
- 作为神经元一氧化氮合成酶 (nNOS) 的不可逆抑制剂对浮囊制剂作进行预先温育处理
生化/生理作用
Nω-硝基-L-精氨酸/L-NNA 有助于降低高碳酸血症导致的皮质充血和大脑 cGMP的水平。
组成型一氧化氮合酶（nNOS）的不可逆抑制剂和诱导型一氧化氮合酶（iNOS）的可逆抑制剂。
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, type N95 (US)
Nitric oxide modulates excitation-contraction coupling in the diaphragm
Reid M B, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology, 119(1), 211-218 (1998)
L-NNA decreases cortical hyperemia and brain cGMP levels following CO2 inhalation in Sprague-Dawley rats
Irikura K, et al.
The American Journal of Physiology, 267(2), H837-H843 (1994)
Cyclic GMP is a second messenger by which nitric oxide inhibits diaphragm contraction
Abraham R Z, et al.
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology, 119(1), 177-183 (1998)
Richard E Klabunde et al.
Journal of vascular research, 39(3), 238-245 (2002-07-05)
Platelet-activating factor (PAF), released during inflammatory responses, increases microvascular permeability to fluid and macromolecules. Previous studies in the hamster cheek pouch microcirculation have shown that PAF-induced increases in permeability can be diminished by pretreatment with a nitric oxide synthase inhibitor
Mark W Gorman et al.
American journal of physiology. Heart and circulatory physiology, 299(6), H1981-H1989 (2010-09-21)
The adenine nucleotide hypothesis postulates that the ATP released from red blood cells is broken down to ADP and AMP in coronary capillaries and that ATP, ADP, and AMP act on purinergic receptors on the surface of capillary endothelial cells.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持